ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 80 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $22,084,000 | -24.3% | 1,001,572 | +0.8% | 0.15% | -24.6% |
| Q1 2016 | $29,188,000 | -19.4% | 993,825 | -9.3% | 0.20% | -16.1% |
| Q4 2015 | $36,192,000 | -52.5% | 1,096,064 | -48.0% | 0.24% | -7.3% |
| Q3 2015 | $76,214,000 | +25.7% | 2,108,890 | +56.5% | 0.26% | -23.2% |
| Q2 2015 | $60,638,000 | +75.7% | 1,347,828 | +19.6% | 0.34% | +71.7% |
| Q1 2015 | $34,516,000 | -38.8% | 1,127,238 | +1.6% | 0.20% | -39.1% |
| Q4 2014 | $56,425,000 | -23.0% | 1,109,644 | -40.1% | 0.32% | +54.8% |
| Q3 2014 | $73,272,000 | +112.0% | 1,851,746 | +130.8% | 0.21% | +12.3% |
| Q2 2014 | $34,557,000 | +63.3% | 802,359 | +51.6% | 0.19% | +59.8% |
| Q1 2014 | $21,168,000 | – | 529,343 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |